Kathleen C. Rayeroux
- Hematology top 10%
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 3
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
-
- RNA modifications and cancer 2
- Protein Degradation and Inhibitors 2
-
- Acute Lymphoblastic Leukemia research 2
-
- Advanced Breast Cancer Therapies 1
-
- T-cell and Retrovirus Studies 1
- Co-authors
- Lynda J. CampbellJeff SzerE. JanuszewiczW. Douglas FairlieAndrew W. RobertsJohn F. SeymourKylie D. MasonSeong Lin Khaw
- Cited by
- HematologyGeneticsRheumatology
- Journals
- International Journal of Cancer (2 papers)Leukemia (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Kathleen C. Rayeroux
10 papers receiving 215 citations
Peers
Comparison fields: 5 of 34
- Hematology 109
- Genetics 91
- Rheumatology 37
- Cancer Research 34
- Oncology 50
Countries citing papers authored by Kathleen C. Rayeroux
This map shows the geographic impact of Kathleen C. Rayeroux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen C. Rayeroux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen C. Rayeroux more than expected).
Fields of papers citing papers by Kathleen C. Rayeroux
This network shows the impact of papers produced by Kathleen C. Rayeroux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen C. Rayeroux. The network helps show where Kathleen C. Rayeroux may publish in the future.
Co-authorship network
The 24 scholars most cited alongside Kathleen C. Rayeroux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 5 | |
| 2 | 2009 | 78 | |
| 3 | 2009 | 15 | |
| 4 | 2002 | 2 | |
| 5 | 2002 | 62 | |
| 6 | 1999 | 9 | |
| 7 | 1999 | 4 | |
| 8 | 1999 | 24 | |
| 9 | 1997 | 24 | |
| 10 | 1997 | 1 |
About Kathleen C. Rayeroux
Kathleen C. Rayeroux is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 10 papers that have together received 224 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), RNA modifications and cancer (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Protein Degradation and Inhibitors (2 papers), Advanced Breast Cancer Therapies (1 paper) and T-cell and Retrovirus Studies (1 paper). The work is most often cited by research in Hematology (109 citations), Genetics (91 citations), Rheumatology (37 citations), Cancer Research (34 citations) and Oncology (50 citations). Kathleen C. Rayeroux has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Lynda J. Campbell, Jeff Szer, E. Januszewicz, W. Douglas Fairlie, Andrew W. Roberts, John F. Seymour, Kylie D. Mason, Seong Lin Khaw, A. Grigg and Edward Chew. Their work appears in journals such as International Journal of Cancer, Leukemia, British Journal of Haematology, Cancer Genetics and Cytogenetics and Methods in molecular biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.